Who
John Gill
Director
Company insider
Files Form 4 as: President and CEO, Altimmune.
In numbers
- Trades disclosed
- 48
- Buys
- 3
- Sells
- 2
- Bought
- $118K
- Sold
- $141K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 9 Oct 2007
- Last trade
- 1 May 2026
- Last filed
- 1 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 May 2026filed 1 May 2026 | ALT Altimmuneoption or derivative · Biotechnology | SEC FORM 4 Code A | —48,800 at $0.00 | filing |
| 1 May 2026filed 1 May 2026 | ALT Altimmuneoption or derivative · Biotechnology | SEC FORM 4 Code A | —48,800 at $0.00 | filing |
| 6 Apr 2026filed 6 Apr 2026 | ALT AltimmuneBiotechnology | SEC FORM 4 Bought | $31K9,200 at $3.41 | filing |
| 6 Apr 2026filed 6 Apr 2026 | ALT AltimmuneBiotechnology | SEC FORM 4 Bought | $31K9,200 at $3.41 | filing |
| 23 Dec 2025filed 23 Dec 2025 | ALT AltimmuneBiotechnology | SEC FORM 4 Bought | $51K12,500 at $4.10 | filing |
| 25 Sep 2025filed 29 Sep 2025 | ALT Altimmuneoption or derivative · Biotechnology | SEC FORM 4 Code A | —48,800 at $0.00 | filing |
| 26 Sep 2024filed 30 Sep 2024 | ALT Altimmuneoption or derivative · Biotechnology | SEC FORM 4 Code A | —34,900 at $0.00 | filing |
| 28 Sep 2023filed 29 Sep 2023 | ALT Altimmuneoption or derivative · Biotechnology | SEC FORM 4 Code A | —26,100 at $0.00 | filing |
| 29 Sep 2022filed 30 Sep 2022 | ALT Altimmuneoption or derivative · Biotechnology | SEC FORM 4 Code A | —23,500 at $0.00 | filing |
| 12 Aug 2022filed 6 Jul 2023 | ALT AltimmuneBiotechnology | SEC FORM 4 Sold | $41K2,714 at $15.00 | filing |
| 6 Jan 2022filed 29 Sep 2025 | ALT AltimmuneBiotechnology | SEC FORM 4 Code G | —2,714 at $0.00 | filing |
| 27 Dec 2021filed 14 Feb 2022 | ALT AltimmuneBiotechnology | SEC FORM 4 Code G | —2,714 at $0.00 | filing |
| 27 Dec 2021filed 14 Feb 2022 | ALT AltimmuneBiotechnology | SEC FORM 4 Code G | —2,714 at $0.00 | filing |
| 23 Sep 2021filed 24 Sep 2021 | ALT Altimmuneoption or derivative · Biotechnology | SEC FORM 4 Code A | —24,100 at $0.00 | filing |
| 3 May 2021filed 14 Feb 2022 | ALT AltimmuneBiotechnology | SEC FORM 4 Code G | —3,000 at $0.00 | filing |
| 30 Nov 2020filed 2 Dec 2020 | ALT AltimmuneBiotechnology | SEC FORM 4 Sold | $100K8,425 at $11.92 | filing |
| 24 Sep 2020filed 16 Oct 2020 | ALT Altimmuneoption or derivative · Biotechnology | SEC FORM 4 Code M | —16,850 at $0.00 | filing |
| 24 Sep 2020filed 16 Oct 2020 | ALT AltimmuneBiotechnology | SEC FORM 4 Code M | —16,850 at $0.00 | filing |
| 24 Sep 2020filed 28 Sep 2020 | ALT Altimmuneoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,500 at $0.00 | filing |
| 25 Jun 2020filed 29 Jun 2020 | ALT Altimmuneoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,850 at $0.00 | filing |
News
Moove In Self Storage's John Gilliland Releases Autobiographyinsideselfstorage.com · 11 Sep 2026
1 headline in the last 90 days name John Gill; 0 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.